Description
BIOMERIEUX BIOFIRE CONSUMABLES
First action · last action
2025-04-03 · 2025-04-03
Transactions
1
First transaction's obligation
$1,201,832
Base + all options value (sum of deltas)
$1,201,832
Extent competed
FULL AND OPEN COMPETITION
Other than full & open authority
—
Set-aside
—
Offers received
—
SDVOSB flag on record
No
Parent IDV
36C25724A0023
NAICS
325413 · IN-VITRO DIAGNOSTIC SUBSTANCE MANUFACTURING
Modification chain · 1 transaction
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2025-04-03+$1,201,832= $1,201,832
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2025-04-03 | +$1,201,832 | $1,201,832 | BIOMERIEUX BIOFIRE CONSUMABLES |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI HCNVCMEG9NL6)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C25926F0276 | NETWORK CONTRACT OFFICE 19 (36C259) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $60,940 | FY2026 |
| 36C25726N0441 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $122,631 | FY2026 |
| 36C25726D0091 | 257-NETWORK CONTRACT OFFICE 17 (36C257) · 6632 · ANALYSIS INSTRUMENTS, MEDICAL LABORATORY USE | $0 | FY2026 |
| 36C26226N0903 | 262-NETWORK CONTRACT OFFICE 22 (36C262) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $67,946 | FY2026 |
| 36C24926N0666 | 249-NETWORK CONTRACT OFFICE 9 (36C249) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $982,841 | FY2026 |
| 36C24126N0842 | 241-NETWORK CONTRACT OFFICE 01 (36C241) · 6550 · IN VITRO DIAGNOSTIC SUBSTANCES, REAGENTS, TEST KITS AND SETS | $310,739 | FY2026 |
Other recipients under 6640 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726F0126 | TEVET LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $139,527 | FY2026 |
| 36C25726P0628 | MOLECULAR DEVICES LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $55,339 | FY2026 |
| 36C25726N0420 | FISHER SCIENTIFIC COMPANY L.L.C. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $534,527 | FY2026 |
| 36C25726P0698 | BRAIN VISION LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $152,025 | FY2026 |
| 36C25726D0085 | FISHER SCIENTIFIC COMPANY L.L.C. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $0 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25725N0249_3600_36C25724A0023_3600 · retrieved 2026-09-26.